Powder X-ray diffraction of capecitabine, C15H22FN3O6 — CORRIGENDUM

James A. Kaduk; Amy M. Gindhart; Thomas N. Blanton

doi:10.1017/S0885715619000642

Powder X-ray diffraction of capecitabine, C15H22FN3O6 — CORRIGENDUM

Published online by Cambridge University Press: 12 September 2019

James A. Kaduk ,

Amy M. Gindhart and

Thomas N. Blanton

Article contents

Abstract
References

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Information

Type: Corrigendum
Information: Powder Diffraction , Volume 34 , Issue 3 , September 2019 , pp. 293

DOI: https://doi.org/10.1017/S0885715619000642 [Opens in a new window]
Copyright: Copyright © International Centre for Diffraction Data 2019

In Kaduk et al. (Reference Kaduk, Gindhart and Blanton2019), Figure 1 showed the incorrect chirality of the molecules.

The correct Figure 1 is shown below:

Figure 1.

(Color online) Powder X-ray diffraction pattern of capecitabine. The Rietveld-refined structure is indicated in red, and the DFT-optimized structure is indicated in blue.

The original article has been corrected online to rectify this error.

References

Kaduk, J. A., Gindhart, A. M., and Blanton, T. N. (2019). “Powder X-ray diffraction of capecitabine, C₁₅H₂₂FN₃O₆,” Powder Diffr. doi:10.1017/S0885715619000575.Google Scholar

Figure 1. (Color online) Powder X-ray diffraction pattern of capecitabine. The Rietveld-refined structure is indicated in red, and the DFT-optimized structure is indicated in blue.